![]() |
市場調查報告書
商品編碼
2008834
醫療機器人系統市場報告:按產品、部署類型、最終用戶和地區分類(2026-2034 年)Medical Robotic Systems Market Report by Product, Deployment Mode, End User, and Region 2026-2034 |
||||||
2025年,全球醫療機器人系統市場規模達263億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到978億美元,2026年至2034年的複合年成長率為15.23%。技術創新、對微創手術需求的成長、慢性病盛行率的上升以及醫療領域的投資是推動市場成長的主要因素。
對微創手術的需求日益成長
微創手術中機器人系統的日益普及正在推動市場成長。由於併發症風險較低且住院時間較短,患者往往更傾向於選擇微創手術。例如,浙江省榮軍醫院於2022年1月至2023年6月進行的一項橫斷面研究,納入了305例靜脈曲張(VV)患者,評估了患者的治療方法偏好趨勢。在96例做出治療方法選擇的患者中,約24.0%選擇了傳統手術,而76.0%選擇了微創手術(MIT)。此外,製造商正在拓展產品線並升級現有系統,以滿足對先進手術能力和技術創新的需求。例如,馬尼帕爾醫院(卡拉迪)於2024年4月推出了一項先進的機器人輔助膝關節關節重建手術,與傳統手術相比,該手術具有更高的精度、更快的恢復速度和更少的不適感。其優點包括植入手術可達亞毫米級精度、降低感染風險以及24小時內即可早期康復出院。這項突破性技術使患者能夠接受微創手術,縮短恢復時間,提高手術精確度,並提升生活品質。這些因素進一步推動了醫療機器人系統市場的成長。
手術機器人的引入
與傳統手術技術相比,手術機器人具有更高的精準度、技巧和準確性,使外科醫生能夠完成複雜的手術。例如,梅奧診所發表的報導指出,機器人技術能夠幫助外科醫生在手術過程中更精準、靈活、可靠地進行操作。與傳統手術技術相比,機器人技術還能提高手術部位的可視性。透過機器人手術,外科醫生可以完成其他技術難以甚至無法完成的複雜精細的治療。此外,有利於機器人輔助手術的監管核准和保險報銷政策也促進了市場成長。醫療監管機構認可機器人系統的臨床優勢,並透過簡化核准流程來推動其應用。例如,2024年3月,Intuitive公司的第五代多埠機器人系統da Vinci 5獲得了食品藥物管理局 510(k)認證。該系統融合了150多項改進,擁有首個力回饋技術、新一代3D顯示和影像處理技術,以及更高的精準度。重新設計的達文西5系統主機,能夠自訂姿勢並在操作主機中更改設置,為外科醫生提供了更大的舒適度。這些因素正在進一步加速全球醫療機器人系統市場的成長。
技術進步
現代醫療機器人系統利用高解析度攝影機、3D視覺化和即時影像處理等先進影像技術。這些技術使外科醫生能夠查看手術部位的詳細放大影像,並精確地操作組織和器官。例如,2024年6月,醫療技術公司Endiatx推出了一款名為「PillBot」的機器人膠囊。這款可口服的機器人膠囊配備了攝影機、感測器和無線通訊功能,使臨床醫生能夠以前所未有的精度和控制力檢查消化道。這種更高的精確度降低了人為誤差的風險,並改善了手術效果,尤其是在複雜的手術中。此外,人工智慧和機器學習演算法正擴大被整合到醫療機器人系統中,以增強決策能力並實現複雜任務的自動化。人工智慧系統能夠即時分析大量數據,預測手術結果,並幫助外科醫生更有效地規劃和執行手術。例如,2023年10月,Body Vision Medical發布了其導航和即時成像平台「LungVision™」的新軟體更新。此次更新包括最新的AI斷層掃描成像演算法、簡化的機器人輔助支氣管鏡檢查(RAB)工作流程,以及降低肺結節切片檢查過程中醫務人員和患者的輻射暴露。這些因素將進一步擴大醫療機器人系統市場的規模。
The global medical robotic systems market size reached USD 26.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 97.8 Billion by 2034, exhibiting a growth rate (CAGR) of 15.23% during 2026-2034. Technological innovations, the rising demand for minimally invasive surgeries, the surging prevalence of chronic diseases, and investment in healthcare are primarily driving the market growth.
Increasing Demand for Minimally Invasive Surgeries
The increasing adoption of robotic systems for minimally invasive surgeries drives the market growth. Patients prefer minimally invasive surgery due to the lower risk of complications and reduced hospitalization periods. For instance, according to a cross-sectional study of 305 VV-afflicted patients at Zhejiang Rongjun Hospital between January 2022 and June 2023 evaluated the treatment preferences of the patients. Out of the 96 patients who selected an option of treatment, nearly 24.0% went with traditional surgery, and 76.0% went with MIT. Moreover, manufacturers are expanding their product offerings and upgrading existing systems to meet the demand for advanced surgical capabilities and technological innovations. For instance, in April 2024, Manipal Hospital, Kharadi, launched advanced robotic knee replacement surgery, which promised more precision, faster recovery times, and less discomfort than traditional surgeries. This provides advantages, such as sub-millimeter accuracy during implant surgery, a lower risk of infection, and the prospect of speedier recovery and release within 24 hours. This breakthrough technique allows patients to have minimally invasive surgery with reduced recovery periods, higher precision, and a better quality of life. These factors are further driving the medical robotic systems market growth.
Adoption of Surgical Robots
Surgical robots offer superior precision, skill, and accuracy compared to traditional surgical techniques. They enable surgeons to perform complex procedures. For instance, according to an article published by Mayo Clinic, during surgery, robotic technology can help surgeons be more precise, flexible, and in control. When compared to conventional surgical techniques, robotic technology also improves the visibility of the operating site. Surgeons can carry out intricate and delicate treatments with robotic surgery that would be challenging or impossible to accomplish with other techniques. Besides this, favorable regulatory approvals and reimbursement policies for robotic-assisted surgeries support market growth. Healthcare regulatory bodies recognize the clinical benefits of robotic systems and encourage their adoption through streamlined approval processes. For example, in March 2024, Intuitive received U.S. Food and Drug Administration (FDA) 510(k) certification for their fifth-generation multiport robotic system, called da Vinci 5. With more than 150 improvements, it boasts the first force-sensing technology, a next-generation 3D display and image processing, and increased precision. With customizable posture and the option to make changes while using the console, the da Vinci 5 system's revamped console provides surgeons with increased comfort. These factors are further escalating the growth of the global medical robotic systems market.
Technological Advancements
Modern medical robotic systems leverage advanced imaging technologies, such as high-definition cameras, 3D visualization, and real-time image processing. These technologies provide surgeons with detailed, magnified views of the surgical site, enabling precise manipulation of tissues and organs. For instance, in June 2024, Endiatx, a medical technology company, unveiled its robotic pill to the market. The PillBot is an ingestible robotic capsule that has cameras, sensors, and wireless communication capabilities, allowing clinicians to investigate the gastrointestinal tract with unprecedented accuracy and control. Enhanced accuracy reduces the risk of human error and improves surgical outcomes, particularly in complex procedures. Besides this, AI and machine learning algorithms are increasingly integrated into medical robotic systems to enhance decision-making capabilities and automate complex tasks. AI-powered systems can analyze vast amounts of data in real-time, predict surgical outcomes, and assist surgeons in planning and executing procedures more effectively. For example, in October 2023, Body Vision Medical launched a new software update for its LungVision(TM) navigation and real-time imaging platform. The update includes the latest AI Tomography imaging algorithm, a streamlined workflow for robotic-assisted bronchoscopy (RAB), reduced radiation exposure for medical staff and patients during lung nodule biopsy procedures, etc. These factors are further driving the medical robotic systems market size.
Surgical robots represented the largest segment
According to the medical robotic systems market overview, surgical robots enable minimally invasive procedures with smaller incisions, reduced trauma to surrounding tissues, and faster recovery times compared to traditional open surgeries. Patients benefit from less pain, shorter hospital stays, and quicker return to normal activities, driving demand for robotic-assisted surgeries. They offer enhanced precision and accuracy in surgical maneuvers, leveraging advanced imaging, robotic arm talent, and real-time feedback mechanisms. Surgeons can perform complex procedures with greater control and precision, minimizing risks and improving surgical outcomes. For instance, in June 2024, SS Innovations, the developer of India's first indigenous surgical robotic system, launched SSI Mantra 3, a robotic system that enables affordable access to the next generation of surgical innovation.
On-premises medical robotic systems are hosted and managed within the healthcare facility's infrastructure, typically within a dedicated surgical suite or operating room. Moreover, healthcare providers have full control over the system's hardware, software, and data management, which is positively influencing the medical robotic systems market prediction. This allows for stringent security measures and compliance with healthcare data privacy regulations. At the same time, cloud-based medical robotic systems leverage cloud computing infrastructure to store data and perform computational tasks remotely. This enables access to robotic capabilities from multiple locations, including different healthcare facilities and remote surgical centers.
Hospitals are major users of medical robotic systems, particularly for complex surgeries that require precision and advanced capabilities. Robotic systems enable surgeons to perform intricate procedures with enhanced precision, reducing the risk of complications and improving patient outcomes. While ASCs increasingly adopt medical robotic systems for performing minimally invasive surgeries (MIS), such as laparoscopic procedures, hernia repairs, and outpatient orthopedic surgeries. Robotic-assisted techniques allow ASCs to offer advanced surgical options with quicker recovery times and reduced post-operative pain. Besides this, in rehabilitation centers, medical robotics are used for neurorehabilitation therapies and assistive technologies. Robotic exoskeletons, prosthetics, and rehabilitation robots help patients regain mobility, improve muscle strength, and facilitate recovery from neurological conditions and musculoskeletal injuries.
North America accounts for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the medical robotic systems market statistics, continuous innovation in robotic technology, including AI integration, advanced imaging capabilities, and enhanced surgical navigation systems, has expanded the applications and precision of medical robotic systems in the region. These advancements improve surgical outcomes and patient safety, driving adoption across various specialties. Moreover, there is an increasing preference for minimally invasive procedures due to reduced recovery times, shorter hospital stays, and improved patient outcomes. Medical robotic systems enable surgeons to perform complex surgeries through smaller incisions with greater precision, enhancing the appeal of robotic-assisted procedures. For instance, in September 2023, U.S. Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) launched the new Canady Robotic AI Surgical System.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: